2 completed, 1 unknown. 2 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow T-Cell Chronic Lymphocytic Leukemia: new trials by email Literature Review of T-Cell Chronic Lymphocytic Leukemia trials Research Report on T-Cell Chronic Lymphocytic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-CD7 CAR-Engineered T Cells for T Lymphoid Malignancies Malignancies Fludarabine + Cyclophosphamide + CAR7-T Cells - T-Cell Lymphocytic Leukemia, T-Cell Chronic Lymphocytic Leukemia | Phase 1 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 24 | 2021-04-15 | 2022-03-16 |
| Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant Allogeneic Hematopoietic Stem Cell Transplantation, Cyclosporine, Fludarabine Phosphate - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 3 | Completed | Fred Hutchinson Cancer Center | 174 | 2010-11-01 | 2026-04-30 |
| Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma Autologous Hematopoietic Stem Cell Transplantation, Autologous-Allogeneic Tandem Hematopoietic Stem Cell Transplantation, Carmustine - Prolymphocytic Leukemia, Recurrent Adult Hodgkin Lymphoma | Phase 1 / Phase 2 | Completed | Fred Hutchinson Cancer Center | 76 | 1999-09-01 | 2020-01-29 |
Leukemia, Prolymphocytic, T-Cell (3) · Hodgkin Disease (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Prolymphocytic (2) · Hematologic Neoplasms (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Leukemia, T-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1) · Myeloproliferative Disorders (1)
Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Leukemia (3) · Leukemia, Lymphoid (3) · Lymphatic Diseases (3) · Lymphoma (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Chronic Disease (2) · Disease Attributes (2) · Leukemia, B-Cell (2) · Leukemia, T-Cell (2)
Cyclophosphamide (2) · Cyclosporine (2) · Cyclosporins (2) · Mycophenolic Acid (2) · Peripheral Blood Stem Cell Transplantation (2) · Whole-Body Irradiation (2) · fludarabine phosphate (2) · Carmustine (1) · Cytarabine (1) · Etoposide (1) · Melphalan (1) · Sirolimus (1) · carmustine, poliferprosan 20 drug combination (1) · fludarabine (1)
Fred Hutchinson Cancer Center (2) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)
Germany (2) · United States (2) · China (1) · Denmark (1)
Brenda Sandmaier (1) · David Maloney (1) · Heng Mei (1)
P30CA015704 (2), P01CA018029 (1)